期刊文献+

慢性心力衰竭患者血浆肾上腺髓质素和cAMP含量的变化及相互关系 被引量:2

Changes in plasma levels of adrenomedullin and cyclic adenosine monophosphate and their interrelation in patients with chronic heart failure
下载PDF
导出
摘要 目的测定慢性心力衰竭(CHF)患者血浆肾上腺髓质素(ADM)和环磷酸腺苷(cAMP)含量的变化,探讨其在心力衰竭发生发展过程中的作用机制。方法 用放射免疫方法测定45例CHF患者和20例健康查体者血浆ADM、cAMP含量,CHF组按美国纽约心脏协会(NYHA)标准进一步分为Ⅱ级、Ⅲ级、Ⅳ级3个组进行比较分析。结果 NYHAⅡ、Ⅲ、Ⅳ级组血浆 ADM、cAMP含量明显高于对照组(P<0.05),在Ⅲ级组达到高峰,Ⅳ级组反而下降;ADM与cAMP存在正相关关系(r=0.735,P<0.01)。结论血浆ADM、cAMP的水平与心功能不全密切相关,在病程不同阶段呈动态变化;ADM与。cAMP之间存在着正相关关系,说明ADM与cAMP存在相互调节作用,cAMP含量的升高部分来源于ADM升高的刺激。 Objective To investigate the changes in plasma levels of adrenomedullin (ADM) and cyclic adenosine monophos-phate (cAMP) in patients with chronic heart failure (CHF) in an attempt to understand the role of ADM in the occurrence and development of CHF. Methods The plasma levels of cAMP and ADM were measured by radioimmunoassay in 45 patients with CHF (including 10 of NYHA class II, 15 of class III, and 20 of class IV) and 20 healthy controls respectively. Results Plasma ADM and cAMP levels significantly increased in patients of NYHA class II, III, and IV as compared with the healthy controls (P<0.05), with those of class M patients being the highest. Positive correlation between ADM and cAMP was noted in CHF patients (r=0.735, P<0.01). Conclusion Plasma levels of ADM and cAMP were in close correlation with the degree of heart failure, varying dynamically with the development of heart failure. There was mutual accommodation between ADM and cAMP, and increased cAMP level partly results from elevated ADM level in CHF patients.
出处 《第一军医大学学报》 CSCD 北大核心 2002年第9期803-805,共3页 Journal of First Military Medical University
基金 国家重大发展基础研究项目(G2000056905)
关键词 慢性心力衰竭 肾上腺髓质素 环磷酸腺苷 放射免疫分析 环磷酸腺苷 CHF ADM heart failure, chronic adrenomedullin cyclic adenosine monophosphate radioimmunoassay
  • 相关文献

参考文献1

  • 1汤健 魏英杰 等.心血管活性肽-基础与临床[M].北京:医科大学、协和医科大学联合出版社,1998.55-80.

共引文献1

同被引文献11

  • 1郭盛,唐于平,宿树兰,段金廒.近10年来中药配伍减毒的现代研究进展[J].中国实验方剂学杂志,2008,14(10):74-79. 被引量:27
  • 2Takahashi M, Nishihira J, Shimpo M, et al. Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes[J]. Cardiovasc Res, 2001, 52(3): 438-45.
  • 3Takahashi M, Nishihira J, Katsuki T, et al. Elevation of plasma levels of macrophage migration inhibitory factor in patients with acute myocardial infarction[ J ]. Am J Cardiol, 2002, 89(2): 248-9.
  • 4Yu CM, Lau CP, Lai KW, et al. Elevation of plasma level macrophage migration inhibitory factor in patients with acute myocardial infarction[J]. Am J Cardiol, 2001, 88(7): 774-7.
  • 5Gando S, Nishihira J, Kemmotsu O, et al. An increase in macropbage migration inhibitory factor release in patients with cardiopulmonary bypass surgery[J]. Surg Today, 2000, 30(8): 689-94.
  • 6Matsumura T, Tsuskima K, Ohtaki E, et al. Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy[J ]. J Cardiol, 2002, 39(5): 253-7.
  • 7Ohtsuka T, Hamada M, Hiasa G, et al. Effect of beta-blockers on circulation levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy[J]. J Am Coll Cardiol, 2001,37(2): 412-7.
  • 8胡高频,张萍,李志梁.充血性心力衰竭患者心肌肌钙蛋白T异构体的表达[J].第一军医大学学报,2001,21(9):671-673. 被引量:2
  • 9高玉琪,李志睴,丁明学,吴宏超,李公信.急性前壁心肌梗死急性期ST段抬高形态与近期预后的关系[J].第一军医大学学报,2002,22(2):156-158. 被引量:4
  • 10Shi Qiu,Ai-Hua Zhang,Hui Sun,Guang-Li Yan,Xi-Jun Wang.Overview on metabolomics in traditional Chinese medicine[J].World Journal of Pharmacology,2014,3(3):33-38. 被引量:9

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部